Superiority of peritoneal dialysis

10^th European Nephrology Conference

October 24-26, 2016 Rome, Italy

Pradip Chowdhury

Peritoneal Dialysis Center of America, USA

Scientific Tracks Abstracts: J Nephrol Ther

Abstract :

Currently 1.9 million of people in the world are undergoing dialysis. This data is based on only people who registered for RRT. We do not know the exact percent of people reaching ESRD, and also who can afford dialysis. Some data suggests initiation of RRT in developing regions is restricted to fewer than a quarter of patients projected to developing ESRD. One of the big factors is the cost of RRT. Peritoneal dialysis may be cheaper, but it is clinically proven to be equivalent or even slightly superior to hemodialysis. This modality is under-utilized in most parts of the world. If we can promote this modality, more people will be benefitted by the effects of peritoneal dialysis. Materials for this talk are based on the articles of ASAN International Peritoneal Dialysis Journal, National Kidney Foundations and Nephrology Dialysis Transplant.

Biography :

Pradip Chowdhury has graduated from Kharkov Medical Institute, Ukraine. He did his Residency in Internal Medicine at Beth Israel Medical Center, Newark, New Jersey. After that, he finished is Fellowship in Nephrology under New York Medical College at San Vincent Hospital, Staten Island New York, and Metropolitan Hospital, New York City, New York. Then he worked as an Attending Nephrologist at Kaiser Permanente, Sacramento, California. Since 2001, he has been working as an Attending Nephrologist at different hospitals in the Los Angeles, and also different dialysis units of DaVita, Fresenius, US Renal Care, and Free Standing Dialysis Unit, Los Angeles. He is the Assistant Medical Director of Peritoneal Dialysis Center of America.

Email: chowdhurypradip@yahoo. com